FDA Submits Proposed Information Collection for OMB Review and Clearance

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its ongoing efforts to assess the benefits and risks of its regulatory activities.